Esophageal squamous cell carcinoma (ESCC): Esophageal Cancer Case 2 скачать в хорошем качестве

Esophageal squamous cell carcinoma (ESCC): Esophageal Cancer Case 2

Esophageal cancer is among the 6th to 8th cause of cancer mortality according to the Global Cancer Observatory. The esophagus is a muscular tube that connects the throat to the stomach. Its symptoms cause a significant impact on patients lives and are often: swallow disorder (dysphagia), unintentional weight loss, heartburn and chest pain. The early treatment for esophageal cancer is imperative for a better prognosis and enhances the chance of the patient survivor. Esophagectomy has an important role in the cancer treatment and minimally invasive approach has been achieving an increasingly solid result in recent years. The ISDE (International Society for Diseases of the Esophagus) hosted a virtual presentation and discussion regarding cancer of the esophagus, managing the disease including surgery for esophageal cancer and other treatment approaches. This recording was part of the Esophageal Cancer Virtual Tumour Board held on August 20, 2020, and moderated by Mark van Berge Henegouwen, Amsterdam University Medical Center (Netherlands) and Lorenzo Ferri, McGill University (Canada). Find out more at https://www.isde.net/esophageal-cancer Learn more about the International Society for Diseases of the Esophagus at https://www.isde.net/ Watch other videos from this virtual presentation • Case 1 – Esophageal Adenocarcinoma (EAC)    • Esophageal Adenocarcinoma (EAC): Esophagea...   • Case 3 – Esophago gastric junction (EGJ) Adenocarcinoma    • Esophago gastric junction (EGJ) Adenocarci...   • Conduit Complications    • Esophageal Cancer Conduit Complications   Check out the Esophageal Cancer playlist    • Esophageal Cancer   ------------- In this video the panel discusses a case of esophageal squamous cell carcinoma (ESCC). Three cases are presented in this webinar of advanced esophageal adenocarcinoma, squamous cell carcinoma, esophago-gastric junction tumors and surgical complications management. Panelists were invited to comment on treatment and management approaches from their respective regions and attendees were invited to submit their perspectives via audience polling at different times during the discussion. ISDE wishes to recognize and thank the following individuals for their contributions to this virtual presentation: • Wayne Hofstetter, MD Anderson Cancer Center (USA) • Simon Law, University of Hong Kong (China) • John Reynolds, Trinity College Dublin (Ireland) • Mark Smithers, University of Queensland (Australia) • Yuko Kitagawa, Keio University (Japan)